- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.09. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 08.09. | Pulsenmore Ltd.: Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring | 128 | PR Newswire | The Pulsenmore FC system is designed to enable women undergoing IVF and fertility preservation treatments to self-perform ultrasound scans from home This registration marks the Company's... ► Artikel lesen | |
| PULSENMORE Aktie jetzt für 0€ handeln | |||||
| 31.08. | Pulsenmore Ltd. reports 1H results | 3 | Seeking Alpha | ||
| 31.08. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 31.08. | Pulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026 | 244 | PR Newswire | Management to Host Webcast today at 8:30 am ET to discuss Results and Provide Business Update
OMER, Israel, Aug. 31, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:... ► Artikel lesen | |
| 19.08. | Pulsenmore expands home ultrasound service to Ichilov hospital | 1 | Investing.com | ||
| 17.08. | Pulsenmore receives $1.27M grant for AI ultrasound program | 1 | Investing.com | ||
| 17.08. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 13.07. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 02.07. | Pulsenmore Ltd. - F-1, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 01.07. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 25.06. | Pulsenmore raises $7.5M in private placement; shares down | 1 | Seeking Alpha | ||
| 25.06. | Pulsenmore raises $7.5 million in private placement | 1 | Investing.com | ||
| 24.06. | Pulsenmore partners with Ouma Health for home ultrasound care | 1 | Investing.com | ||
| 24.06. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 24.06. | Pulsenmore Ltd.: Pulsenmore Announces Strategic Partnership with Ouma Health to Expand Access to Remote Prenatal Care Across the United States | 346 | PR Newswire | FDA-authorized home ultrasound technology to be integrated into Ouma Health's virtual maternity care model, creating a scalable pathway to expand the adoption of home ultrasound in prenatal... ► Artikel lesen | |
| 12.06. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.05. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 30.03. | Pulsenmore Ltd. reports FY results | 1 | Seeking Alpha | ||
| 30.03. | Pulsenmore Ltd.: Pulsenmore Announces Full Year 2025 Financial Results and Webcast | 414 | PR Newswire | Management to Host Conference Call and Webcast today at 8:30am ET to Discuss Results and Provide Business Update
OMER, Israel, March 30, 2026 /PRNewswire/ - Pulsenmore... ► Artikel lesen |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 45,705 | +1,48 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Fresenius mit einem Kursziel von 56 Euro auf "Buy" belassen. Analyst Graham Doyle hält die Sorgen um das US-Geschäft mit... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,990 | +1,99 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,560 | +2,91 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| HEARTFLOW | 49,540 | 0,00 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,27 | -0,05 % | BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell? | ||
| ALIGNMENT HEALTHCARE | 12,935 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| BASEL MEDICAL GROUP | 7,180 | +0,56 % | Morning Market Movers: Aehr Test Systems, Pentair, NextCure, Basel Medical Group See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 14,395 | +0,10 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,390 | 0,00 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 21,025 | 0,00 % | Oppenheimer reiterates Procept BioRobotics stock rating | ||
| CARL ZEISS MEDITEC | 30,280 | -0,07 % | SFC Energy, Dürr, Carl Zeiss Meditec, SFC Energy schauen nach Dehli zum BRIC's Gipfel - und Trump golft | Zeitenwende. Die Musik spielt in Dehli. Carl Zeiss MediTec, SFC Energy, Dürr, Wacker Chemie - you name it. Deutsche Small- und MidCaps müssen die Chance der Veränderung nutzen. Vielelicht noch mehr... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 6,520 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| GENEDX | 89,77 | +0,03 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| BETA BIONICS | 16,710 | -0,12 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| GERRESHEIMER | 27,500 | -2,55 % | EQS-DD: Gerresheimer AG: Active Ownership Opportunities SCS, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
07.09.2026 / 15:24... ► Artikel lesen |
PULSENMORE LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 2,440 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PULSENMORE LTD finden Sie auf Wallstreet Online.